1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Stock Price ?

Discussion in 'Hill-Rom' started by anonymous, Jul 14, 2017 at 6:29 AM.

  1. anonymous

    anonymous Guest

    Hill-Rom stock is trading at a 5 year high but the reason why is unclear. Market fundamentals do not justify nor have their been any recent announcements that would explain the dramatic change in market value? Any thoughts on why?